首页> 外文期刊>Acta Radiologica >Stent implantation in chronic mesenteric ischemia.
【24h】

Stent implantation in chronic mesenteric ischemia.

机译:慢性肠系膜缺血支架植入术。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Chronic mesenteric ischemia (CMI) is a life-threatening disorder, which is usually associated with stenosis or occlusion of celiac or mesenteric arteries. PURPOSE: To review our experience and to assess short-term results of stent placement in stenotic mesenteric arteries. MATERIAL AND METHODS: Primary stent placement was performed in 15 patients who had nausea, vomiting, postprandial pain, and weight loss due to steno-occlusive diseases of mesenteric arteries. After stenting, the patients were followed clinically and with Doppler ultrasound at 1, 6, and 12 months. Symptomatic patients with restenosis were examined with digital subtraction angiography and were referred for retreatment with balloon dilatation. RESULTS: Twenty-three stenoses and 11 occlusions were detected in 15 patients, and 18 stenoses were treated with primary stenting. Single-vessel endovascular treatment was performed in 12 patients. In three patients, two arteries were stented in the same session. Technical success rate was 18/18 (100%). Clinical success was achieved in 13/15 (86.6%) patients. First-month mortality was 13%. During the mean 16.1-month follow-up period, restenoses developed in three patients. One of them was successfully treated with balloon angioplasty. Primary patency was 9/11 (81%) and primary assisted patency was 81% at 12 months. The complication rate was 1/15 patients (0.06%). CONCLUSION: Our experience suggests that stent placement has a potential role in chronic mesenteric ischemia with low incidence of complications and high technical and clinical success rates.
机译:背景:慢性肠系膜缺血(CMI)是威胁生命的疾病,通常与腹腔或肠系膜动脉狭窄或闭塞有关。目的:回顾我们的经验并评估狭窄肠系膜动脉中支架置入的短期结果。材料和方法:对15例因肠系膜动脉狭窄闭塞性疾病而引起的恶心,呕吐,餐后疼痛和体重减轻的患者进行了一次支架置入术。支架置入后,对患者进行临床随访,分别在第1、6和12个月进行多普勒超声检查。有症状的再狭窄患者通过数字减影血管造影检查,并接受球囊扩张再治疗。结果:15例患者中发现23处狭窄和11处阻塞,并且18处狭窄经原发支架置入治疗。 12例患者进行了单支血管内治疗。在三名患者中,在同一疗程中置入了两条动脉。技术成功率为18/18(100%)。在13/15(86.6%)的患者中取得了临床成功。首个月死亡率为13%。在平均16.1个月的随访期内,三名患者发生了再狭窄。其中之一已成功进行球囊血管成形术治疗。在12个月时,主要通畅率为9/11(81%),主要辅助通畅率为81%。并发症发生率为1/15例(0.06%)。结论:我们的经验表明,支架置入在慢性肠系膜缺血中具有潜在作用,并发症发生率低,技术和临床成功率高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号